Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 3:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 992 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Insomnia Disorders Clear all

Conditions: Chronic Insomnia
Interventions: Cognitive-Behavior Therapy, Behavior Therapy, Cognitive Therapy; Other
Lead sponsor: Laval University; Other
Eligibility: 25 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Sleep Disturbance
Interventions: chilipad; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Insomnia
Interventions: Digital cognitive behavioral therapy for insomnia (CBT-I) program, Minimally Enhanced Usual Care (mEUC), Somryst (culturally adapted); Behavioral · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Insomnia, Arthritis, Rheumatoid
Interventions: Eszopiclone, placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 25 Years to 64 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 38
States / cities: Huntsville, Alabama • Tucson, Arizona • Santa Maria, California + 35 more

Conditions: Insomnia
Interventions: HIRREM; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: HIV/AIDS, Insomnia
Interventions: SHUTi; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Insomnia
Interventions: Dexmedetomidine, Zolpidem; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Insomnia
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 19
States / cities: Birmingham, Alabama • Hot Springs, Arkansas • Los Angeles, California + 16 more

Conditions: Sleep Disturbance, Insomnia
Interventions: Transcranial Electrical Neuromodulation (TES); Device
Lead sponsor: Brain Electrophysiology Laboratory Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Insomnia Disorder
Interventions: Cognitive Behavioral Therapy for Insomnia, Passive Body Heating (PBH); Behavioral · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Insomnia, Generalized Anxiety Disorder
Interventions: Eszopiclone (Lunesta); Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 64
States / cities: Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 61 more

Conditions: Fibromyalgia, Insomnia
Interventions: Behavioral insomnia therapy; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Poor Sleep Quality
Interventions: HealthyHabits1, HealthyHabits2, Snack 2, Snack 1; Behavioral · Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Insomnia
Interventions: white noise; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Palatal Donor Site Wound Healing, Platelet Rich Fibrin, Sleep Quality, Pain, Analgesic Consumption
Interventions: Platelet rich fibrin, Control Group: collagen matrices or oxidized cellulose membrane; Procedure · Other
Lead sponsor: 59th Medical Wing; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Substance Use, Stress, Relation, Interpersonal, Bullying, Victimisation, Mental Health Issue, Sleep, Inadequate, Social Skills
Interventions: PeerLearning.net; Behavioral
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: Not listed
Enrollment: 924 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Trauma, Insomnia, Nightmares
Interventions: Cognitive Processing Therapy-Cognitive Only (CPT), Cognitive Behavioral Therapy of Insomnia and Nightmares (CBTin), Continuation Cognitive Processing Therapy-Cognitive Only (CPT); Behavioral
Lead sponsor: University of North Texas, Denton, TX; Other
Eligibility: 18 Years to 50 Years
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Fort Hood, Texas

Conditions: Insomnia
Interventions: Suvorexant, Placebo; Drug
Lead sponsor: Burdick, Daniel, M.D.; Individual
Eligibility: 30 Years to 80 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Adenovirus, Anesthesia, Anxiety, Anxiolysis, Autism, Autistic Disorder, Bacterial Meningitis, Bacterial Septicemia, Benzodiazepine, Bipolar Disorder, Bone and Joint Infections, Central Nervous System Infections, Convulsions, Cytomegalovirus Retinitis, Early-onset Schizophrenia Spectrum Disorders, Epilepsy, General Anesthesia, Gynecologic Infections, Herpes Simplex Virus, Infantile Hemangioma, Infection, Inflammation, Inflammatory Conditions, Intra-abdominal Infections, Lower Respiratory Tract Infections, Migraines, Pain, Pneumonia, Schizophrenia, Sedation, Seizures, Skeletal Muscle Spasms, Skin and Skin-structure Infections, Treatment-resistant Schizophrenia, Urinary Tract Infections, Withdrawal, Sepsis, Gram-negative Infection, Bradycardia, Cardiac Arrest, Cardiac Arrhythmia, Staphylococcal Infections, Nosocomial Pneumonia, Neuromuscular Blockade, Methicillin Resistant Staphylococcus Aureus, Endocarditis, Neutropenia, Headache, Fibrinolytic Bleeding, Pulmonary Arterial Hypertension, CMV Retinitis, Hypertension, Chronic Kidney Diseases, Hyperaldosteronism, Hypokalemia, Heart Failure, Hemophilia, Heavy Menstrual Bleeding, Insomnia
Interventions: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:; Drug
Lead sponsor: Daniel Benjamin; Other
Eligibility: Up to 21 Years
Enrollment: 3,520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 43
States / cities: Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more

Conditions: Sleep Initiation and Maintenance Disorders, Osteoarthritis
Interventions: Cognitive behavioral therapy (CBT) for insomnia, Behavioral desensitization treatment for insomnia; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 35 Years to 100 Years
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bladder Function
Interventions: cystometry, polysomnography; Procedure
Lead sponsor: Astellas Pharma Inc; Industry
Eligibility: 45 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Sleep Quality
Interventions: Magnesium Breakthrough, Placebo; Dietary Supplement
Lead sponsor: Jacksonville University; Other
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Insomnia, Depression
Interventions: Digital Insomnia Program, Digital Mental Health Program, Psychoeducation; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older · Female only
Enrollment: 747 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Autism Spectrum Disorder, Insomnia
Interventions: COGMUSE-AUT; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

Cognitive-Behavior Therapy for Insomnia

Reports on Sleep Quality and Thermoregulation Among Veterans

Digital Cognitive-Behavioral Therapy for Insomnia in Spanish Speaking Latinas/os (Dormir Mejor Study)

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) to Relieve Insomnia

Cognitive Behavioral Therapy to Treat Insomnia in Persons With HIV Infection

Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

Closed Loop TES for Enhancing Slow Wave Sleep

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study

Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder

Behavioral Insomnia Therapy for Fibromyalgia

Improving Sleep In Midlife Women

The Effect of White Noise In High Noise Environment

Characterizing the Effects of Platelet-Rich Fibrin (PRF) as a Palatal Wound Dressing on Quality of Life and Sleep Following Mucogingival Surgery. Study Was Conducted at the Air Force Post Graduate Dental School. All HIPPA Consents and Research Informed Consents Are Located at JBSA-Lackland.

Automating Peer Learning to Reduce Alcohol Use and Related Deviant Behavior in Secondary School

Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)

A Pilot Study of Suvorexant for Insomnia in Parkinson Disease

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Sleep in Osteoarthritis Project

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Magnesium Supplement for Sleep Quality in Women With Poor Sleep

Evaluating the Impact of Digital Behavioral Interventions to Address Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design

Novel Adaptive Cognitive Training in Autistic Adults With Co-occurring Insomnia